Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Biogen Investigacion FI



Biogen Investigacion FI (BIOINVS:SM) was acquired by POP:SM

Company Profile

Biogen Investigacion FI an open-end fund incorporated in Spain. The Fund's objective is capital appreciation. The Fund invests in international equity securities that are engaged in the health and biotechnology sector, mainly in the OECD markets. Additionally, The Fund invests in derivative instruments.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
sec ||= nil